✦ LIBER ✦

Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study

✍ Scribed by F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino; S. Campbell; S. A. Marsico; A. Bianco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating weekly administration of pac

✍ David Aguiar; José Aguiar; Uriel Bohn 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Phase II study of gemcitabine and carbop

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

Paclitaxel and gemcitabine combination i

✍ Athanasios Athanasiadis; George Roussos; Thomas Papakostoulis; Daniela-Carmen At 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 197 KB

Gemcitabine pharmacokinetics and interac

✍ Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

A phase II study of ifosfamide and a2b-i

✍ M. J. Lind; S. Gomm; A. P. Simmonds; L. Ashcroft; A. Kamthan; H. Gurney; N. That 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 295 KB